Skip to content

Treatment for Acute Postoperative Voiding Dysfunction

Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of Acute Postoperative Voiding Dysfunction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01189136
Acronym
PTNS
Enrollment
84
Registered
2010-08-26
Start date
2006-07-31
Completion date
2013-12-31
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Retention

Keywords

Voiding dysfunction

Brief summary

If patients are unable to have their foley catheter removed because their bladder is not emptying well, they may be eligible for study participation. This study is designed to evaluate whether Posterior Tibial Nerve Stimulation is effective in improving bladdder function after surgery. Study participation is limited to one day.

Detailed description

If patients fail a voiding trial (the test done to see if a foley catheter is ready to be removed after surgery), they may be offered participation in this trial. Patients are randomized to receive active treatment or a sham treatment. A small, accupuncture-type needle is inserted through the skin just above the ankle. A small, battery-powered generator will be attached to the needle. The generator will give a low-voltabe stimulation which is adjusted for comfort level and applied for 30 minutes. After treatemnt, the voiding trial will be repeated.

Interventions

DEVICEPTNS Active Treatment

34 gauge needle inserted 3cm above the medial ankle, and cables are connected to the PTNS stimulator device. Stimulation is provided, per manufacturer directions, over a 30-minute treatment period.

OTHERSham treatment

34 gauge needle inserted 3cm above the medial ankle, but nonconductive cables are connected, so that no electrical stimulation is applied, over a 30-minute treatment period

Sponsors

Women and Infants Hospital of Rhode Island
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 95 Years
Healthy volunteers
Yes

Inclusion criteria

* First voiding trial after Urogynecological surgery shows that bladder is not emptying well.

Exclusion criteria

* Patient declines participation.

Design outcomes

Primary

MeasureTime frameDescription
Persistent Retention30 minutesNumber of participants with persistent unsuccessful trial of void after the intervention

Secondary

MeasureTime frameDescription
Amount of Improvement in Voiding Efficiency30 minutesImprovement of voiding efficiency, as measured by dividing the volume voided by the total volume (voided volume + retained volume) per participant. Each participant is evaluated separately, and the mean percentage of improvement was calculated for each arm.

Other

MeasureTime frameDescription
Questionnaire Data - Impression of Allocation30 minutesParticipants were asked to guess to which treatment arm they had been allocated (PTNS Sham or I Don't Know). Outcome was measured as the number of patients in each arm accurately determining their allocation.
Pain From Treatment30 minutesPatient-reported discomfort attributable to the study intervention (0-10 Likert scale, with higher numbers representing greater pain)

Countries

United States

Participant flow

Recruitment details

112 subjects invited to participate, 28 declined, and 84 were equally distributed between treatment and sham groups

Participants by arm

ArmCount
Sham Treatment
No electrical stimulation is actually received Sham treatment: No electrical stimulation is given
42
Peructaneous Tibial Nerve Stimulation
Patient receives PTNS for 30 minutes PTNS treatment: Electrical stimulation is received
42
Total84

Baseline characteristics

CharacteristicSham TreatmentPeructaneous Tibial Nerve StimulationTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants6 Participants9 Participants
Age, Categorical
Between 18 and 65 years
39 Participants36 Participants75 Participants
Age, Customized46 years
STANDARD_DEVIATION 8
54 years
STANDARD_DEVIATION 11
50 years
STANDARD_DEVIATION 9
BMI29.0 kg/m2
STANDARD_DEVIATION 3.1
28.7 kg/m2
STANDARD_DEVIATION 3.5
28.9 kg/m2
STANDARD_DEVIATION 3.3
Gender
Female
42 Participants42 Participants84 Participants
Gender
Male
0 Participants0 Participants0 Participants
Parity2 pregnancies
STANDARD_DEVIATION 1
2 pregnancies
STANDARD_DEVIATION 1
2 pregnancies
STANDARD_DEVIATION 1

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 420 / 42
serious
Total, serious adverse events
0 / 420 / 42

Outcome results

Primary

Persistent Retention

Number of participants with persistent unsuccessful trial of void after the intervention

Time frame: 30 minutes

ArmMeasureValue (NUMBER)
Sham TreatmentPersistent Retention29 participants
Peructaneous Tibial Nerve StimulationPersistent Retention21 participants
Secondary

Amount of Improvement in Voiding Efficiency

Improvement of voiding efficiency, as measured by dividing the volume voided by the total volume (voided volume + retained volume) per participant. Each participant is evaluated separately, and the mean percentage of improvement was calculated for each arm.

Time frame: 30 minutes

ArmMeasureValue (MEAN)Dispersion
Sham TreatmentAmount of Improvement in Voiding Efficiency21 percentage of voided vol/total volumeStandard Deviation 8
Peructaneous Tibial Nerve StimulationAmount of Improvement in Voiding Efficiency28 percentage of voided vol/total volumeStandard Deviation 5
Other Pre-specified

Pain From Treatment

Patient-reported discomfort attributable to the study intervention (0-10 Likert scale, with higher numbers representing greater pain)

Time frame: 30 minutes

ArmMeasureValue (MEAN)Dispersion
Sham TreatmentPain From Treatment0.14 units on a scaleStandard Deviation 0.08
Peructaneous Tibial Nerve StimulationPain From Treatment0.55 units on a scaleStandard Deviation 0.09
Other Pre-specified

Questionnaire Data - Impression of Allocation

Participants were asked to guess to which treatment arm they had been allocated (PTNS Sham or I Don't Know). Outcome was measured as the number of patients in each arm accurately determining their allocation.

Time frame: 30 minutes

Population: Number

ArmMeasureValue (NUMBER)
Sham TreatmentQuestionnaire Data - Impression of Allocation10 number of participants
Peructaneous Tibial Nerve StimulationQuestionnaire Data - Impression of Allocation41 number of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026